𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Follicular lymphomas — a review of treatment modalities

✍ Scribed by Pierre Soubeyran; Marc Debled; Nadine Tchen; Pierre Richaud; Alain Monnereau; Françoise Bonichon; Houchingue Eghbali

Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
152 KB
Volume
35
Category
Article
ISSN
1040-8428

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Assessment of follicular lymphomas
Assessment of follicular lymphomas
✍ Peter A. Hall; John Crocker; Michael A. Richards 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB
Long-term results of treatment of patien
Long-term results of treatment of patients with follicular lymphomas
✍ S. Kalter; L. Holmes; F. Cabanillas 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 555 KB

The management of patients with follicular lymphoma is controversial, particularly in those with follicular small cleaved cell (FSCC) or nodular poorly differentiated lymphoma (NPDL). Some advocate no treatment until symptoms arise, while others prefer to treat with intensive combination regimens an

Primary cutaneous lymphomas: a review wi
Primary cutaneous lymphomas: a review with current treatment options
✍ Christiane Querfeld; Joan Guitart; Timothy M. Kuzel; Steven T. Rosen 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 293 KB

Primary cutaneous T- and B-cell lymphomas are a heterogenous group of diseases with varied clinical presentations and prognosis. The use of new molecular, histological, and clinical criteria have enhanced the recognition of primary cutaneous T- and B-cell lymphomas. Compared to their nodal counterpa

The role of fludarabine in the treatment
The role of fludarabine in the treatment of follicular and mantle cell lymphoma
✍ Georg Lenz; Wolfgang Hiddemann; Martin Dreyling 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB 👁 1 views

## Abstract Advanced‐stage follicular lymphoma (FL) and mantle cell lymphoma (MCL) cannot be cured using conventional chemotherapy. Fludarabine, the most widely used purine analog, exhibits a particularly high level of activity against small lymphocytic lymphoma and chronic lymphocytic leukemia (CL